Australia, March 3 -- Merck KGaA, owns the trademark (2574902) for 'EZMEKLY' till Dec. 7, 2033.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for human use for the treatment of oncology, neuro-oncology, tumors, cancer, and rare diseases; pharmaceutical preparations for human use for the treatment of neurofibromatosis; small molecule therapeutic preparations for human use for the treatment of oncology, neuro-oncology, tumors, cancer, and rare diseases; small molecule therapeutic preparations for human use for the treatment of neurofibromatosis.]
Type of Mark: Word
Date of Acceptance: Oct. 21, 2025
Registration Advertised: March 2
For further details contact Merck KGaA.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2574902.
Disclaimer: Curated by HT Syndication.
